Mar 19, 2026
77:75
For every 75 shares held, investors received 77. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
Percheron Therapeutics Limited (ASX:PER) operates in the Pharmaceuticals: major industry.
Percheron Therapeutics Limited company overviewPercheron Therapeutics Limited's most recent stock split was on March 19, 2026. It was a 77-for-75 forward split, so shareholders received 77 shares for every 75 they held.
Percheron Therapeutics Limited (ASX:PER) has split its stock 4 times: a 7-for-6 split on November 4, 2010, a 1-for-10 reverse split on November 20, 2013, a 50-for-49 split on April 10, 2018, and a 77-for-75 split on March 19, 2026.
Percheron Therapeutics Limited has split its stock 4 times. This history records 4 splits between November 4, 2010 and March 19, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Percheron Therapeutics Limited's 77-for-75 split on March 19, 2026, every 75 shares became 77 shares.
Percheron Therapeutics Limited has not announced a new split in our records. Its most recent split was on March 19, 2026, less than a year ago. Companies announce splits in advance, and any new ASX:PER split will appear on this page.
Already premium?